Next Article in Journal
Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells
Previous Article in Journal
High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
Previous Article in Special Issue
Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Addendum

Addendum: Rehnelt et al. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634

1
Institute of Physiology I, Medical Faculty, University of Bonn, 53127 Bonn, Germany
2
Nanion Technologies GmbH, 80636 Munich, Germany
3
Part of the Ncardia Group, Axiogenesis AG, 50829 Cologne, Germany
4
Research Training Group 1873, University of Bonn, 53127 Bonn, Germany
*
Authors to whom correspondence should be addressed.
Present address: Institute for Nanoelectronics, Department of Electrical Engineering and Information Technology, Technische Universität München, 80333 Munich, Germany.
Present address: Institute for Cardiovascular Physiology, University Medical Center Goettingen, 37073 Goettingen, Germany.
Int. J. Mol. Sci. 2021, 22(11), 5562; https://doi.org/10.3390/ijms22115562
Submission received: 9 March 2021 / Accepted: 15 March 2021 / Published: 25 May 2021
(This article belongs to the Special Issue Optogenetic Approaches in Neuroscience)
The authors would like to indicate that the commercial human cardiomyocytes used in the study (Cor.4U©, NCardia/Axiogenesis AG, Cologne, Germany) [1] were believed to be derived from human induced pluripotent stem cells during the studies. After the studies had been completed and published, short tandem repeat testing by NCardia determined that Cor.4U© cardiomyocytes revealed the genetic background of the human embryonic stem cell line RUES2. The different provenience of these well-characterized cardiomyocytes changes neither our findings nor the interpretation of our data.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Rehnelt, S.; Malan, D.; Juhasz, K.; Wolters, B.; Doerr, L.; Beckler, M.; Kettenhofen, R.; Bohlen, H.; Bruegmann, T.; Sasse, P. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rehnelt, S.; Malan, D.; Juhasz, K.; Wolters, B.; Doerr, L.; Beckler, M.; Kettenhofen, R.; Bohlen, H.; Bruegmann, T.; Sasse, P. Addendum: Rehnelt et al. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634. Int. J. Mol. Sci. 2021, 22, 5562. https://doi.org/10.3390/ijms22115562

AMA Style

Rehnelt S, Malan D, Juhasz K, Wolters B, Doerr L, Beckler M, Kettenhofen R, Bohlen H, Bruegmann T, Sasse P. Addendum: Rehnelt et al. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634. International Journal of Molecular Sciences. 2021; 22(11):5562. https://doi.org/10.3390/ijms22115562

Chicago/Turabian Style

Rehnelt, Susanne, Daniela Malan, Krisztina Juhasz, Benjamin Wolters, Leo Doerr, Matthias Beckler, Ralf Kettenhofen, Heribert Bohlen, Tobias Bruegmann, and Philipp Sasse. 2021. "Addendum: Rehnelt et al. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634" International Journal of Molecular Sciences 22, no. 11: 5562. https://doi.org/10.3390/ijms22115562

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop